Validation of the OncoDEEP® Kit comprehensive genomic panel on the MGI platform

Introduction :

This study aims to compare tumour characterization using the OncoDEEP® Kit end-to-end solution with an MGI sequencer as an alternative to Illumina technology. The validation results demonstrate that the MGI platform, by generating high-quality data, represents an excellent alternative, with all variant and fusion detections being comparable. Furthermore, the correlation of genomic signatures using data from MGI sequencing shows a high concordance with Illumina. Explore this poster to discover why MGI technology might be considered a cost-effective alternative to Illumina technology.

You may also be interested in these resources

Share This